FDA Approves First Drug to Image Tau Pathology in Patients Being Evaluated for Alzheimer ’s Disease

FDA approved Tauvid for IV injection, the first drug used to help image a distinctive characteristic of Alzheimer ’s disease in the brain called tau pathology. Tauvid is a radioactive diagnostic agent for adult patients with cognitive impairment who are being evaluated for Alzheimer’s disease.
Source: FDA Center for Drug Evaluation and Research - What's New - Category: Drugs & Pharmacology Authors: Source Type: news